National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

DMID Resources for Researchers
 Animal Models for Experimental Therapies and Vaccines
 Invasive Aspergillosis Animal Models
 Animal Models for Hepatitis B and C
 BEI Resources
 Clinical Laboratory Diagnostics for Invasive Aspergillosis
 Clinical Agents and Specimen Repository
 Regulatory Affairs Support
 Collaborative Antiviral Study Group
 Filariasis
 In Vitro and Animal Models
 International Clinical Sciences Support Center
 In Vitro Antiviral Screening Program
 Leprosy Research Support
 Malaria Vaccine Production Services
 MR4
 NARSA
 Biosafety Laboratories
 Phase I Clinical Trial Units for Therapeutics
 Preclinical Development of Therapeutic Agents
 Respiratory Pathogens Translational Research Services
 Schistosomiasis Resource Center
 Sexually Transmitted Infections Clinical Trials Group
 STEC
 TARGET
 TB Vaccine Research and Testing
 Topical Microbicides
 WRCEVA


Services for Researchers

Tuberculosis Clinical Diagnostics Research Consortium (CDRC)

About

What services does this resource provide?

The Tuberculosis Clinical Diagnostics Research Consortium (CDRC) will evaluate diagnostic tests and strategies in TB endemic countries. These efforts will be supported by clinicians familiar with the process for diagnosis or exclusion of TB. CDRC sites will serve diverse populations of patients, including HIV-positive and negative patients, pediatric patients and patients with other co-infections and co-morbid conditions. The CDRC will also provide information to the greater community of TB investigators about TB diagnostic development.

Additional information about the CDRC will be forthcoming.

Contact Info

Karen Lacourciere
Program Officer
Respiratory Diseases Branch, DMID
E-mail:
lacourcierek@niaid.nih.gov




 

Contact Info

Karen Lacourciere
Program Officer
Respiratory Diseases Branch, DMID
E-mail:
lacourcierek@niaid.nih.gov